Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A new Revision: v3.5.4 label was added for the Study Protocol and Statistical Analysis Plan, signaling an updated version of the document. The previous Revision: v3.5.3 label was removed (superseded).
    Difference
    0.1%
    Check dated 2026-05-14T22:54:07.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new page revision v3.5.3 was added and the previous revision v3.5.2 was removed. This update documents a change to the page's versioning on the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-04-30T15:23:54.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.2; the previous v3.5.0 revision was removed.
    Difference
    0.1%
    Check dated 2026-04-16T09:33:30.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page. This appears to be a site revision and does not modify the study details displayed.
    Difference
    0.1%
    Check dated 2026-03-25T19:48:10.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    System revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:12:48.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice and NIH Clinical Center operating status banner, and added a Revision: v3.4.2 tag. The core study content and user-facing information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:57:42.000Z thumbnail image

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.